You are here

Home

Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is P  [Clear All Filters]
2021
Dewan R, Chia R, Ding J, Hickman RA, Stein TD, Abramzon Y, Ahmed S, Sabir MS, Portley MK, Tucci A et al..  2021.  Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.. Neuron. 109(3):448-460.e4.
Damotte V, van der Lee SJ, Chouraki V, Grenier-Boley B, Simino J, Adams H, Tosto G, White C, Terzikhan N, Cruchaga C et al..  2021.  Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants.. Alzheimers Dement. 17(10):1663-1674.
Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JPaul, Teich AF et al..  2021.  Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.. Alzheimers Dement. 17(8):1353-1364.
Sariya S, Felsky D, Reyes-Dumeyer D, Lali R, Lantigua RA, Vardarajan B, Jimenez-Velazquez IZ, Haines JL, Shellenberg GD, Pericak-Vance MA et al..  2021.  Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.. Ann Neurol. 90(3):366-376.
Wu J, Dong Q, Gui J, Zhang J, Su Y, Chen K, Thompson PM, Caselli RJ, Reiman EM, Ye J et al..  2021.  Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases.. Front Neurosci. 15:669595.
Ramos-Miguel A, Jones AA, Petyuk VA, Barakauskas VE, Barr AM, Leurgans SE, De Jager PL, Casaletto KB, Schneider JA, Bennett DA et al..  2021.  Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample.. Acta Neuropathol. 141(5):755-770.
2020
Bush WS, Wheeler N, Beaulieu-Jones B, Darabos C.  2020.  Packaging Biocomputing Software to Maximize Distribution and Reuse.. Pac Symp Biocomput. 25:739-742.
Tang Z-Z, Sliwoski GR, Chen G, Jin B, Bush WS, Li B, Capra JA.  2020.  PSCAN: Spatial scan tests guided by protein structures improve complex disease gene discovery and signal variant detection.. Genome Biol. 21(1):217.
2019
Tan CHong, Bonham LW, Fan CChieh, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Yokoyama JS, Rabinovici GD, Miller BL et al..  2019.  Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.. Brain. 142(2):460-470.
Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, Fox NC, Williams J, Hardy J, Escott-Price V.  2019.  Polygenic risk and hazard scores for Alzheimer's disease prediction.. Ann Clin Transl Neurol. 6(3):456-465.
Liu Y, Wang M, Marcora EM, Zhang B, Goate AM.  2019.  Promoter DNA hypermethylation - Implications for Alzheimer's disease.. Neurosci Lett. 711:134403.
Choi KYeong, Lee JJae, Gunasekaran TIniyan, Kang S, Lee W, Jeong J, Lim HJae, Zhang X, Zhu C, Won S-Y et al..  2019.  Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of ε4 on Alzheimer's Disease Risk in a Multiracial Sample.. J Clin Med. 8(8)
Sun D, Tiedt S, Yu B, Jian X, Gottesman RF, Mosley TH, Boerwinkle E, Dichgans M, Fornage M.  2019.  A prospective study of serum metabolites and risk of ischemic stroke.. Neurology. 92(16):e1890-e1898.
Feliciano-Astacio BE, Celis K, Ramos J, Rajabli F, Adams LDeon, Rodriguez A, Rodriguez V, Bussies PL, Sierra C, Manrique P et al..  2019.  The Puerto Rico Alzheimer Disease Initiative (PRADI): A Multisource Ascertainment Approach.. Front Genet. 10:538.

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer